Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN79,379,58-0,33
Msft285,96285,98-2,79
Nokia4,7094,727-2,62
IBM137,49137,52-0,75
Daimler AG76,1176,140,57
PFE43,0443,05-1,21
28.09.2021 20:29:38
Indexy online
AD Index online
select
AD Index online
 

  • 28.09.2021 20:29:47
Integra Lifesci (IART.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
70,89 -1,41 -1,02 111 677
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 28.09.2021
Popis společnosti
Obecné informace
Název společnostiIntegra Lifesciences Holdings Corp
TickerIART
TickerIARTL
Kmenové akcie:Ordinary Shares
Kmenové akcie:Ordinary Shares
RICIARTL.PK^B11
RICIART.O
ISIN-
Prioritní akciePreference Shares
Prioritní akciePreference Shares
RICTLIOP.OB^I95
Poslední známé roční výsledky31.12.2020
Poslední známé čtvrtletní výsledky30.06.2021
Počet zaměstnanců k 31.12.2020 3 700
Akcie v oběhu k 27.07.2021 84 579 542
MěnaUSD
Konstituent indexůS&P 400 Mid Cap
Kontaktní informace
Ulice1100 CAMPUS ROAD
MěstoPRINCETON
PSČ08540
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon16 092 750 500
Fax16097504277

Business Summary: Integra LifeSciences Holdings Corporation provides regenerative technologies and neurosurgical solutions. The Company offers a portfolio of brands including AmnioExcel, Bactiseal, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, SurgiMend, TCC-EZ, and VersaTru. The Company offers solutions in orthopedics, neurosurgery, and reconstructive and general surgery. The Company operates through two segments: Codman Specialty Surgical segment, and Orthopedics and Tissue Technologies segment. The Codman Specialty Surgical segment includes the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care. The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.
Financial Summary: BRIEF: For the six months ended 30 June 2021, IntegraLifesciences Holdings Corp revenues increased 22% to$750.1M. Net income increased from $8.8M to $80.5M.Revenues reflect an increase in demand for the Company'sproducts and services due to favorable market conditions.Net income benefited from Corporate segment loss decreaseof 22% to $122.4M, amortization segment loss decrease of72% to $4.2M.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYScientific & Technical Instr.
MGSECTORTechnology
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Offices of Other Holding Companies
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Offices of Other Holding Companies
SICAnalytical Instruments
SICAnalytical Instruments
SICSurgical Appliances And Supplies
SICSurgical And Medical Instruments
SICHolding Companies, Nec



  • Poslední aktualizace: 28.09.2021
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the BoardStuart Essig5807.06.2012
President, Chief Executive Officer, DirectorPeter Arduini5603.01.201201.11.2010
Chief Financial Officer, Executive Vice PresidentCarrie Anderson5224.06.201924.06.2019
Chief Operating Officer, Executive Vice PresidentGlenn Coleman5324.06.201902.05.2014
Executive Vice President, Chief Human Resources OfficerLisa Evoli51
Executive Vice President, Chief Legal Officer, SecretaryEric Schwartz5212.11.2018
Executive Vice President, President - Tissue TechnologiesRobert Davis62
Executive Vice President and President - Codman Specialty SurgicalMichael Mcbreen5508.06.202008.06.2020
Senior Vice President, Principal Accounting OfficerJeffrey Mosebrook4417.10.2017